Compare FLYW & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLYW | BHC |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2021 | 1996 |
| Metric | FLYW | BHC |
|---|---|---|
| Price | $14.39 | $5.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 3 |
| Target Price | ★ $16.21 | $8.00 |
| AVG Volume (30 Days) | ★ 2.1M | 1.7M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 450.00 | 423.08 |
| EPS | ★ 0.10 | N/A |
| Revenue | $623,025,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $19.68 | $4.61 |
| Revenue Next Year | $15.25 | N/A |
| P/E Ratio | $145.80 | ★ N/A |
| Revenue Growth | ★ 26.59 | N/A |
| 52 Week Low | $10.09 | $4.76 |
| 52 Week High | $18.05 | $8.69 |
| Indicator | FLYW | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 41.40 | 45.73 |
| Support Level | $12.82 | $4.93 |
| Resistance Level | $15.13 | $6.31 |
| Average True Range (ATR) | 0.63 | 0.20 |
| MACD | -0.32 | -0.02 |
| Stochastic Oscillator | 16.22 | 49.28 |
Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements, namely a payments platform, a proprietary payment network, and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.